Voloridge Investment Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $393,785 - $578,140	15,479 Added 36.85%	57,486 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $1.01 Million - $1.36 Million	42,007 New	42,007 $1.2 Million
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $553,825 - $1.24 Million	-31,396 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $573,363 - $797,343	-16,765 Reduced 34.81%	31,396 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $4.71 Million - $9.83 Million	-168,762 Reduced 77.8%	48,161 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $1.86 Million - $3.03 Million	-71,956 Reduced 24.91%	216,923 $7.34 Million
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $9.25 Million - $20.8 Million	238,728 Added 476.02%	288,879 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $1.74 Million - $6.2 Million	50,151 New	50,151 $2.18 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.